A Non-Invasive Cervical Cancer Screening Modality: A Pilot Study
A Non-Invasive Cervical Cancer Screening Modality: A Pilot Study
Cervix cancer is a major global health concern. A way to screen and immediately treat
 precancerous lesions (Screen-and-Treat) is greatly needed. Developed by MobileOCT, polarized
 difference imaging and conventional imaging are used to identify suspicious lesions. We aim
 to compare this non-invasive method with colposcopy. Patients at the Dickens Clinic will have
 3-5 minutes of non-invasive imaging before colposcopy. Pathology will be compared both to
 colposcopy impression versus MobileOCT.
Inclusion Criteria:

 -  Subjects capable of giving informed consent or have an acceptable surrogate capable of
 giving consent on subjects behalf.

 -  Subjects are 18 years of age or older

 -  Subjects are scheduled for colposcopy clinic based on screening with abnormal pap
 smear or have repeat colposcopy indicated for specific clinical indications, based off
 of American Society of Cosposcopy and Cytology.

 -  Subjects are women.

 Exclusion Criteria:

 -  Pregnancy.

 -  Males (males do not have a cervix and thus cannot undergo colposcopy).